4
Dear Colleague, We are pleased to invite you to what we hope will be a very exciting and intensive CME-accredited educational activity designed specifically for physicians and advance practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and consider the impact of clinical comorbidities such as nutritional deficits and CF related diabetes. We will also interview a patient with cystic fibrosis and then discuss collectively strategies to improve patient and family education. Topics to be brought up will include ensuring smooth transitioning from pediatric to adult care, and implementing techniques to empower our patients and improve their treatment adherence. This educational activity is designed to be highly interactive and will be limited to a small number of participants. Please plan to register soon. We look forward to seeing you! Henry L. Dorkin, MD Program Chairman Henry L. Dorkin, MD Director, Pulmonary Clinical Research Program Co-Director, Cystic Fibrosis Center Boston Children’s Hospital Co-Director, Cystic Fibrosis Foundation Therapeutic Development Center at Children’s Associate Professor of Pediatrics Harvard Medical School Boston, MA Marcia Katz, MD, FACP, FCCP The Brown Foundation Professor of Adult Cystic Fibrosis Associate Chair of Medicine for Clinical Affairs Director, Adult Cystic Fibrosis Center Professor of Medicine Baylor College of Medicine Head of Adult Medicine Texas Children’s Hospital Pavilion for Women Houston, TX BOSTON CYSTIC FIBROSIS SUMMIT CURRENT TRENDS AND FUTURE DIRECTIONS Gregory S. Sawicki, MD, MPH Director, Cystic Fibrosis Center Boston Children’s Hospital Assistant Professor in Pediatrics Harvard Medical School Boston, MA Peter J. Mogayzel, Jr., MD, PhD, MBA Professor of Pediatrics Director, Cystic Fibrosis Center Johns Hopkins School of Medicine Baltimore, MD

NEW ENGLAND FIBROSIS SUMMIT CURRENT TRENDS AND CYSTIC FIBROSIS CYSTIC …mosbrookdesign.com/ABcomm/CFBoston/CFBoston.pdf · 2016. 6. 13. · Co-Director, Cystic Fibrosis Foundation

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: NEW ENGLAND FIBROSIS SUMMIT CURRENT TRENDS AND CYSTIC FIBROSIS CYSTIC …mosbrookdesign.com/ABcomm/CFBoston/CFBoston.pdf · 2016. 6. 13. · Co-Director, Cystic Fibrosis Foundation

ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046

Dear Colleague,

We are pleased to invite you to what we hope will be a very exciting and intensive CME-accredited educational activity designed specifically for physicians and advance practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and consider the impact of clinical comorbidities such as nutritional deficits and CF related diabetes.

We will also interview a patient with cystic fibrosis and then discuss collectively strategies to improve patient and family education. Topics to be brought up will include ensuring smooth transitioning from pediatric to adult care, and implementing techniques to empower our patients and improve their treatment adherence.

This educational activity is designed to be highly interactive and will be limited to a small number of participants. Please plan to register soon. We look forward to seeing you!

Henry L. Dorkin, MD Program Chairman

Henry L. Dorkin, MDDirector, Pulmonary Clinical Research ProgramCo-Director, Cystic Fibrosis CenterBoston Children’s HospitalCo-Director, Cystic Fibrosis Foundation TherapeuticDevelopment Center at Children’sAssociate Professor of PediatricsHarvard Medical SchoolBoston, MA

Marcia Katz, MD, FACP, FCCP The Brown Foundation Professor of Adult Cystic FibrosisAssociate Chair of Medicine for Clinical AffairsDirector, Adult Cystic Fibrosis CenterProfessor of MedicineBaylor College of MedicineHead of Adult MedicineTexas Children’s Hospital Pavilion for WomenHouston, TX

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

ITWEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Supported by an independent educational grant from Gilead Sciences Medical Affairs.

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Provided by ABcomm, Inc.

Saturday, September 10, 2016 • 8:00 am – 2:30 pmBoston Marriott NewtonNewton, MA

SEPT

10Gregory S. Sawicki, MD, MPHDirector, Cystic Fibrosis Center Boston Children’s HospitalAssistant Professor in Pediatrics Harvard Medical SchoolBoston, MA

Peter J. Mogayzel, Jr., MD, PhD, MBAProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD

Saturday, September 10, 2016 8:00 am – 2:30 pmBoston Marriott NewtonNewton, MA

Page 2: NEW ENGLAND FIBROSIS SUMMIT CURRENT TRENDS AND CYSTIC FIBROSIS CYSTIC …mosbrookdesign.com/ABcomm/CFBoston/CFBoston.pdf · 2016. 6. 13. · Co-Director, Cystic Fibrosis Foundation

PROGRAM AGENDA

8:00 am – 8:30 am CME Registration / Continental Breakfast

8:30 am – 8:45 am Welcome and Introduction Henry L. Dorkin, MD – Program Chairman

8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview

9:30 am – 10:15 am The Current Lay of the Land Henry L. Dorkin, MD

10:15 am – 10:30 am Break

10:30 am – 11:30 am The Big Picture – Infection Prevention to Chronic Suppression

Peter J. Mogayzel, Jr., MD

11:30 am – 12:15 pm CFTR Modulation – Where We Are and Where We Are Headed

Marcia F. Katz, MD

12:15 pm – 1:15 pm Lunch / Panel Discussion All Faculty

1:15 pm – 1:45 pm Transitioning to Adulthood – It’s Complicated! Marcia F. Katz, MD

1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success

Gregory S. Sawicki, MD

2:15 pm – 2:30 pm Concluding Remarks and Evaluation Henry L. Dorkin, MD

LEARNING OBJECTIVESAs a result of attending this program, participants will be able to: Determine the clinical relevance of consequential respiratory

pathogens. Choose among available aerosolized antibiotics by comparing safety,

efficacy, and long-term study data. Decide if a CFTR modulator is an appropriate addition to the treatment

plan based on patient specific criteria including mutation analysis. Involve the patient and/or family in decision making and outcome

monitoring in order to increase commitment to the treatment plan. Educate patient and family regarding best practices to prevent the

incidence and spread of infection. Screen older patients for nutritional deficits, comorbidities, mental

health issues, and difficulties with treatment adherence. Develop a comprehensive treatment strategy for the presented

patient case.

ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATIONABcomm, Inc. designates this live educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an evaluation form in order to receive a certificate of credit. Certificates will be emailed to participants 4 – 6 weeks after the activity.

DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities.

Saturday, September 10, 2016 • 8:00 am – 2:30 pm Marriott Boston Newton

REGISTRATION PROCEDURERegistrations will be accepted through Friday, September 2, 2016 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.

Registrations can be submitted using one of the following methods:

ONLINE: Go to www.cfsummitboston.eventbrite.com

TELEPHONE: Contact us at (913) 313-7657 during regular business hours.

FAX/SCAN: Complete the written application form and email to [email protected] or fax to (866) 353-6169.

MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.

FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.

REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by September 2, 2016.

LODGING Overnight accommodations at the Boston Marriott Newton are available at preferred rates from $161 per night plus taxes. Please make reservations at http://bit.ly/1T7FZme or call (617) 969-1000 by Friday, July 15, 2016 and request the Boston CF Summit Rate. If you need a reservation after Friday, July 15, please contact Kristi Day at (913) 313-7657 or [email protected]. A limited number of rooms are available, so please inquire early.

Boston Marriott Newton2345 Commonwealth AvenueNewton, MA 02466(617) 969-1000

Parking is available free of charge for day guests, and $11.00 per night for overnight guests.

PROFESSIONAL INFORMATION

WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER

ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE

ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER MONTH?

HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE

WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?

IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:

IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:

FIRST NAME LAST NAME DEGREE(S)

TITLE INSTITUTION

ADDRESS CITY STATE

ZIP PHONE EMAIL

PAYMENT INFORMATION

Visa MasterCard American Express Discover Check (mailed with registration form)

CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE

BILLING ADDRESS

REGISTRATION FORM

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

REGISTRATION DEADLINE: FRIDAY, SEPTEMBER 2, 2016

Register online at www.cfsummitboston.eventbrite.com

REGISTER ONLINE ATwww.cfsummitboston.eventbrite.com

Page 3: NEW ENGLAND FIBROSIS SUMMIT CURRENT TRENDS AND CYSTIC FIBROSIS CYSTIC …mosbrookdesign.com/ABcomm/CFBoston/CFBoston.pdf · 2016. 6. 13. · Co-Director, Cystic Fibrosis Foundation

PROGRAM AGENDA

8:00 am – 8:30 am CME Registration / Continental Breakfast

8:30 am – 8:45 am Welcome and Introduction Henry L. Dorkin, MD – Program Chairman

8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview

9:30 am – 10:15 am The Current Lay of the Land Henry L. Dorkin, MD

10:15 am – 10:30 am Break

10:30 am – 11:30 am The Big Picture – Infection Prevention to Chronic Suppression

Peter J. Mogayzel, Jr., MD

11:30 am – 12:15 pm CFTR Modulation – Where We Are and Where We Are Headed

Marcia F. Katz, MD

12:15 pm – 1:15 pm Lunch / Panel Discussion All Faculty

1:15 pm – 1:45 pm Transitioning to Adulthood – It’s Complicated! Marcia F. Katz, MD

1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success

Gregory S. Sawicki, MD

2:15 pm – 2:30 pm Concluding Remarks and Evaluation Henry L. Dorkin, MD

LEARNING OBJECTIVESAs a result of attending this program, participants will be able to: Determine the clinical relevance of consequential respiratory

pathogens. Choose among available aerosolized antibiotics by comparing safety,

efficacy, and long-term study data. Decide if a CFTR modulator is an appropriate addition to the treatment

plan based on patient specific criteria including mutation analysis. Involve the patient and/or family in decision making and outcome

monitoring in order to increase commitment to the treatment plan. Educate patient and family regarding best practices to prevent the

incidence and spread of infection. Screen older patients for nutritional deficits, comorbidities, mental

health issues, and difficulties with treatment adherence. Develop a comprehensive treatment strategy for the presented

patient case.

ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATIONABcomm, Inc. designates this live educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an evaluation form in order to receive a certificate of credit. Certificates will be emailed to participants 4 – 6 weeks after the activity.

DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities.

Saturday, September 10, 2016 • 8:00 am – 2:30 pm Marriott Boston Newton

REGISTRATION PROCEDURERegistrations will be accepted through Friday, September 2, 2016 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.

Registrations can be submitted using one of the following methods:

ONLINE: Go to www.cfsummitboston.eventbrite.com

TELEPHONE: Contact us at (913) 313-7657 during regular business hours.

FAX/SCAN: Complete the written application form and email to [email protected] or fax to (866) 353-6169.

MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.

FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.

REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by September 2, 2016.

LODGING Overnight accommodations at the Boston Marriott Newton are available at preferred rates from $161 per night plus taxes. Please make reservations at http://bit.ly/1T7FZme or call (617) 969-1000 by Friday, July 15, 2016 and request the Boston CF Summit Rate. If you need a reservation after Friday, July 15, please contact Kristi Day at (913) 313-7657 or [email protected]. A limited number of rooms are available, so please inquire early.

Boston Marriott Newton2345 Commonwealth AvenueNewton, MA 02466(617) 969-1000

Parking is available free of charge for day guests, and $11.00 per night for overnight guests.

PROFESSIONAL INFORMATION

WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER

ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE

ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER MONTH?

HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE

WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?

IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:

IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:

FIRST NAME LAST NAME DEGREE(S)

TITLE INSTITUTION

ADDRESS CITY STATE

ZIP PHONE EMAIL

PAYMENT INFORMATION

Visa MasterCard American Express Discover Check (mailed with registration form)

CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE

BILLING ADDRESS

REGISTRATION FORM

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

REGISTRATION DEADLINE: FRIDAY, SEPTEMBER 2, 2016

Register online at www.cfsummitboston.eventbrite.com

REGISTER ONLINE ATwww.cfsummitboston.eventbrite.com

Page 4: NEW ENGLAND FIBROSIS SUMMIT CURRENT TRENDS AND CYSTIC FIBROSIS CYSTIC …mosbrookdesign.com/ABcomm/CFBoston/CFBoston.pdf · 2016. 6. 13. · Co-Director, Cystic Fibrosis Foundation

ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046

Dear Colleague,

We are pleased to invite you to what we hope will be a very exciting and intensive CME-accredited educational activity designed specifically for physicians and advance practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and consider the impact of clinical comorbidities such as nutritional deficits and CF related diabetes.

We will also interview a patient with cystic fibrosis and then discuss collectively strategies to improve patient and family education. Topics to be brought up will include ensuring smooth transitioning from pediatric to adult care, and implementing techniques to empower our patients and improve their treatment adherence.

This educational activity is designed to be highly interactive and will be limited to a small number of participants. Please plan to register soon. We look forward to seeing you!

Henry L. Dorkin, MD Program Chairman

Henry L. Dorkin, MDDirector, Pulmonary Clinical Research ProgramCo-Director, Cystic Fibrosis CenterBoston Children’s HospitalCo-Director, Cystic Fibrosis Foundation TherapeuticDevelopment Center at Children’sAssociate Professor of PediatricsHarvard Medical SchoolBoston, MA

Marcia Katz, MD, FACP, FCCP The Brown Foundation Professor of Adult Cystic FibrosisAssociate Chair of Medicine for Clinical AffairsDirector, Adult Cystic Fibrosis CenterProfessor of MedicineBaylor College of MedicineHead of Adult MedicineTexas Children’s Hospital Pavilion for WomenHouston, TX

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Supported by an independent educational grant from Gilead Sciences Medical Affairs.

BOSTON

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

NEW ENGLAND

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

WEST COAST

CYSTIC FIBROSIS

CURRENT TRENDS ANDFUTURE DIRECTIONSSU

MM

IT

Provided by ABcomm, Inc.

Saturday, September 10, 2016 • 8:00 am – 2:30 pmBoston Marriott NewtonNewton, MA

SEPT

10Gregory S. Sawicki, MD, MPHDirector, Cystic Fibrosis Center Boston Children’s HospitalAssistant Professor in Pediatrics Harvard Medical SchoolBoston, MA

Peter J. Mogayzel, Jr., MD, PhD, MBAProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD

Saturday, September 10, 2016 8:00 am – 2:30 pmBoston Marriott NewtonNewton, MA